Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$937,869,169
+$211,486,339 QoQ
Shares Held
781,929
-1.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#86
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $3,483,940,248 across 16 Drug Manufacturers - General names. LLY ranks #1 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
781,929 | $937,869,169 | |
| 2 | JNJ |
Johnson & Johnson
|
2,675,500 | $679,496,724 | |
| 3 | ABBV |
AbbVie Inc.
|
1,621,115 | $407,937,369 | |
| 4 | AZN |
Astrazeneca PLC
|
2,033,587 | $385,608,756 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,578,024 | $331,276,081 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,215,423 | $242,892,664 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,070,731 | $135,276,147 | |
| 8 | PFE |
Pfizer Inc
|
5,482,863 | $132,027,333 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $937,869,169 | 781,929 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $726,382,830 | 789,744 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $716,239,887 | 666,468 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $447,803,174 | 586,898 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $434,751,667 | 557,710 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $541,488,885 | 655,627 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $559,326,352 | 724,516 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $586,951,189 | 662,518 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $523,497,951 | 578,208 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $443,753,045 | 570,406 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $301,255,380 | 516,804 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $273,127,914 | 508,495 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $222,820,835 | 475,118 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $176,527,491 | 514,028 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $168,722,476 | 461,192 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $143,236,932 | 442,978 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $144,427,276 | 445,447 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $121,609,021 | 424,657 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $125,690,316 | 455,037 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $93,184,077 | 403,307 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $89,990,428 | 392,081 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $70,142,311 | 375,454 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $118,670,033 | 702,855 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $104,161,815 | 703,701 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $91,690,258 | 558,474 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $69,704,300 | 502,482 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||